Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Colorectal carcinoma infiltration by myeloperoxidase-expressing neutrophil granulocytes is associated with favorable prognosis.

Hirt C, Eppenberger-Castori S, Sconocchia G, Iezzi G, Tornillo L, Terracciano L, Spagnoli GC, Droeser RA.

Oncoimmunology. 2013 Oct 1;2(10):e25990. Epub 2013 Sep 12.

2.

High myeloperoxidase positive cell infiltration in colorectal cancer is an independent favorable prognostic factor.

Droeser RA, Hirt C, Eppenberger-Castori S, Zlobec I, Viehl CT, Frey DM, Nebiker CA, Rosso R, Zuber M, Amicarella F, Iezzi G, Sconocchia G, Heberer M, Lugli A, Tornillo L, Oertli D, Terracciano L, Spagnoli GC.

PLoS One. 2013 May 29;8(5):e64814. doi: 10.1371/journal.pone.0064814. Print 2013.

3.

Absence of myeloperoxidase and CD8 positive cells in colorectal cancer infiltrates identifies patients with severe prognosis.

Däster S, Eppenberger-Castori S, Hirt C, Soysal SD, Delko T, Nebiker CA, Weixler B, Amicarella F, Iezzi G, Governa V, Padovan E, Mele V, Sconocchia G, Heberer M, Terracciano L, Kettelhack C, Oertli D, Spagnoli GC, von Holzen U, Tornillo L, Droeser RA.

Oncoimmunology. 2015 May 29;4(12):e1050574. eCollection 2015 Dec.

4.

GM-CSF Production by Tumor Cells Is Associated with Improved Survival in Colorectal Cancer.

Nebiker CA, Han J, Eppenberger-Castori S, Iezzi G, Hirt C, Amicarella F, Cremonesi E, Huber X, Padovan E, Angrisani B, Droeser RA, Rosso R, Bolli M, Oertli D, von Holzen U, Adamina M, Muraro MG, Mengus C, Zajac P, Sconocchia G, Zuber M, Tornillo L, Terracciano L, Spagnoli GC.

Clin Cancer Res. 2014 Jun 15;20(12):3094-106. doi: 10.1158/1078-0432.CCR-13-2774. Epub 2014 Apr 15.

5.

OX40 expression enhances the prognostic significance of CD8 positive lymphocyte infiltration in colorectal cancer.

Weixler B, Cremonesi E, Sorge R, Muraro MG, Delko T, Nebiker CA, Däster S, Governa V, Amicarella F, Soysal SD, Kettelhack C, von Holzen UW, Eppenberger-Castori S, Spagnoli GC, Oertli D, Iezzi G, Terracciano L, Tornillo L, Sconocchia G, Droeser RA.

Oncotarget. 2015 Nov 10;6(35):37588-99. doi: 10.18632/oncotarget.5940.

6.

Urokinase-type plasminogen activator is a marker of aggressive phenotype and an independent prognostic factor in mismatch repair-proficient colorectal cancer.

Minoo P, Baker K, Baumhoer D, Terracciano L, Lugli A, Zlobec I.

Hum Pathol. 2010 Jan;41(1):70-8. doi: 10.1016/j.humpath.2009.05.013. Epub 2009 Sep 8.

PMID:
19740518
7.
8.

Intratumoral budding as a potential parameter of tumor progression in mismatch repair-proficient and mismatch repair-deficient colorectal cancer patients.

Lugli A, Vlajnic T, Giger O, Karamitopoulou E, Patsouris ES, Peros G, Terracciano LM, Zlobec I.

Hum Pathol. 2011 Dec;42(12):1833-40. doi: 10.1016/j.humpath.2011.02.010. Epub 2011 Jun 12.

PMID:
21664647
9.

TIA-1 cytotoxic granule-associated RNA binding protein improves the prognostic performance of CD8 in mismatch repair-proficient colorectal cancer.

Zlobec I, Karamitopoulou E, Terracciano L, Piscuoglio S, Iezzi G, Muraro MG, Spagnoli G, Baker K, Tzankov A, Lugli A.

PLoS One. 2010 Dec 10;5(12):e14282. doi: 10.1371/journal.pone.0014282.

10.

Renal neutrophils infiltration in antineutrophil cytoplasmic antibodies-negative pauci-immune crescentic glomerulonephritis.

Xing GQ, Chen M, Liu G, Wang SX, Zhao MH.

Am J Med Sci. 2010 Dec;340(6):474-80. doi: 10.1097/MAJ.0b013e3181f0768e.

PMID:
21119331
11.

CD8/CD45RO T-cell infiltration in endoscopic biopsies of colorectal cancer predicts nodal metastasis and survival.

Koelzer VH, Lugli A, Dawson H, Hädrich M, Berger MD, Borner M, Mallaev M, Galván JA, Amsler J, Schnüriger B, Zlobec I, Inderbitzin D.

J Transl Med. 2014 Mar 29;12:81. doi: 10.1186/1479-5876-12-81.

12.

Telomere length in peripheral leukocytes is associated with immune cell tumor infiltration and prognosis in colorectal cancer patients.

Svenson U, Öberg Å, Stenling R, Palmqvist R, Roos G.

Tumour Biol. 2016 Aug;37(8):10877-82. doi: 10.1007/s13277-016-4987-0. Epub 2016 Feb 16.

PMID:
26883253
13.

PD-L1 expression in colorectal cancer is associated with microsatellite instability, BRAF mutation, medullary morphology and cytotoxic tumor-infiltrating lymphocytes.

Rosenbaum MW, Bledsoe JR, Morales-Oyarvide V, Huynh TG, Mino-Kenudson M.

Mod Pathol. 2016 Sep;29(9):1104-12. doi: 10.1038/modpathol.2016.95. Epub 2016 May 20.

PMID:
27198569
14.

High frequency of tumor-infiltrating FOXP3(+) regulatory T cells predicts improved survival in mismatch repair-proficient colorectal cancer patients.

Frey DM, Droeser RA, Viehl CT, Zlobec I, Lugli A, Zingg U, Oertli D, Kettelhack C, Terracciano L, Tornillo L.

Int J Cancer. 2010 Jun 1;126(11):2635-43. doi: 10.1002/ijc.24989.

15.

Differential diagnostic and functional role of the multi-marker phenotype CDX2/CK20/CK7 in colorectal cancer stratified by mismatch repair status.

Lugli A, Tzankov A, Zlobec I, Terracciano LM.

Mod Pathol. 2008 Nov;21(11):1403-12. doi: 10.1038/modpathol.2008.117. Epub 2008 Jun 27.

16.

Prognostic significance of mammalian sterile20-like kinase 1 in colorectal cancer.

Minoo P, Zlobec I, Baker K, Tornillo L, Terracciano L, Jass JR, Lugli A.

Mod Pathol. 2007 Mar;20(3):331-8. Epub 2007 Feb 2.

17.

Co-expression of nuclear and cytoplasmic HMGB1 is inversely associated with infiltration of CD45RO+ T cells and prognosis in patients with stage IIIB colon cancer.

Peng RQ, Wu XJ, Ding Y, Li CY, Yu XJ, Zhang X, Pan ZZ, Wan DS, Zheng LM, Zeng YX, Zhang XS.

BMC Cancer. 2010 Sep 16;10:496. doi: 10.1186/1471-2407-10-496.

18.

Mismatch repair gene defects in sporadic colorectal cancer enhance immune surveillance.

Scarpa M, Ruffolo C, Canal F, Scarpa M, Basato S, Erroi F, Fiorot A, Dall'Agnese L, Pozza A, Porzionato A, Castagliuolo I, Dei Tos AP, Bassi N, Castoro C.

Oncotarget. 2015 Dec 22;6(41):43472-82. doi: 10.18632/oncotarget.6179.

19.

Prognostic role of CD10⁺ myeloid cells in association with tumor budding at the invasion front of colorectal cancer.

Khanh do T, Mekata E, Mukaisho K, Sugihara H, Shimizu T, Shiomi H, Murata S, Naka S, Yamamoto H, Endo Y, Tani T.

Cancer Sci. 2011 Sep;102(9):1724-33. doi: 10.1111/j.1349-7006.2011.01987.x. Epub 2011 Jun 23.

20.

Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review.

Nosho K, Baba Y, Tanaka N, Shima K, Hayashi M, Meyerhardt JA, Giovannucci E, Dranoff G, Fuchs CS, Ogino S.

J Pathol. 2010 Dec;222(4):350-66. doi: 10.1002/path.2774. Review.

Supplemental Content

Support Center